This content is in French.
Batoclimab in myasthenia gravis
8 mars 2024
In this multicenter randomized clinical trial conducted from September 15, 2021 to June 29, 2022 at 27 centers in China, investigators evaluated the efficacy and safety profile of batoclimab, an anti-IgG1…
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Chong Yan et al. Batoclimab vs Placebo for Generalized Myasthenia Gravis: A Randomized Clinical Trial. JAMA Neurol. 2024 Mar 4.
View the source
